04.03.2009 18:27:00
|
PDI, Inc. to Hold Fourth Quarter and Full Year 2008 Financial Results Conference Call on Wednesday, March 11, 2009
PDI, Inc. (NASDAQ:PDII), a pioneer in providing contract sales and commercialization services to the biopharmaceutical industry, today announced that it will release its fourth quarter and full year 2008 financial results on Wednesday, March 11, 2009 after the market close.
PDI will host an investment community conference call beginning at 4:30 p.m. Eastern time on March 11, 2009 to discuss these results and to answer questions.
To participate in the live conference call by telephone, please dial (866) 644-4654 from the U.S., or for international callers, please dial (706) 643-1203.
Those interested in listening to the conference call live via the Internet may do so by visiting the Investor Relations section of PDI’s web site at http://www.pdi-inc.com. A replay will be available on the web site. A telephone replay will be available from 5:30 p.m. Eastern time on March 11, 2009 through 11:59 p.m. Eastern time on March 13, 2009 by dialing (800) 642-1687 (domestic) or (706) 645-9291 (international) and entering conference ID number 88865012.
About PDI
PDI provides commercialization services for established and emerging biopharmaceutical companies. The Company is dedicated to maximizing the return on investment for its clients by providing strategic flexibility, sales, marketing and commercialization expertise.
PDI currently operates in three business segments: Sales Services, Marketing Services and Product Commercialization. Our sales services include Performance Sales Teams™, which are dedicated pharmaceutical sales force teams for specific customers; Select Access™, our targeted sales solution that leverages an existing sales force and infrastructure; and PDI ON DEMAND, a suite of innovative sales services that provide rapid, customized sales force solutions tailored to meet the local, regional and seasonal needs of our customers. Our marketing services include marketing research and consulting services through TVG, and promotional physician interaction programs through Pharmakon. Our product commercialization solutions leverage our considerable sales and marketing expertise to manage products throughout their lifecycles. PDI's experience extends across multiple therapeutic categories and includes office- and hospital-based initiatives.
For more information, please visit the Company’s website at www.pdi-inc.com.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu PDI Inc.mehr Nachrichten
Keine Nachrichten verfügbar. |